Anzeige
Mehr »
Login
Sonntag, 23.06.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Kursrakete startet...: Jetzt einsteigen und von außergewöhnlichem Potenzial profitieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EU6F | ISIN: DK0062498333 | Ticker-Symbol: NOV
Xetra
21.06.24
17:35 Uhr
132,64 Euro
-1,04
-0,78 %
1-Jahres-Chart
NOVO NORDISK A/S Chart 1 Jahr
5-Tage-Chart
NOVO NORDISK A/S 5-Tage-Chart
RealtimeGeldBriefZeit
132,52132,9022.06.
132,52132,9021.06.
PR Newswire
413 Leser
Artikel bewerten:
(2)

Novo Nordisk Foundation and the Wellcome Trust award a grant of up to DKK 585 million to the Ancient Environmental Genomics Initiative for Sustainability ('AEGIS')

COPENHAGEN, Denmark, June 11, 2024 /PRNewswire/ -- In an era where climate change poses a critical threat to biodiversity and agricultural productivity, a pioneering research project that harnesses environmental DNA ('eDNA'), sets out to transform future global cropping systems and to develop resilient crops in the face of climate change.

The Novo Nordisk Foundation has awarded a grant to AEGIS of up to DKK 500 million over seven years, with an additional DKK 85 million funded by the Wellcome Trust.

AEGIS is led by the evolutionary geneticist Professor Eske Willerslev from the University of Copenhagen and University of Cambridge. The initiative aims to decode and understand how ecosystems and crops have responded and adapted to past environmental perturbations and is driven by the aspiration to create a more sustainable future by enhancing crop resilience and agroecosystem sustainability.

"Understanding how entire ecosystems and individual species function and have adapted to environmental challenges over the course of millennia will enable the creation of new resilient crops that can withstand and mitigate climate change. AEGIS has the potential to break scientific barriers in a number of fields, while simultaneously revolutionising plant breeding and increasing the resilience of agroecosystems in both the Global South and Global North." says Mads Krogsgaard Thomsen, CEO, Novo Nordisk Foundation.

"Agricultural systems and the foods we grow have changed over millennia. We currently know very little about past ecosystems and what changes in biodiversity might have occurred as the environment changed. AEGIS hopes to build the evidence base needed to strengthen the resilience of food systems across the world in the face of future environmental changes," elaborated John-Arne Røttingen, CEO, Wellcome Trust.

"By employing ecosystem modelling, we can pinpoint which combinations of species led to the most durable ecosystems in the past. This knowledge could serve as a blueprint for creating climate resilient food systems, enhancing both the crops we grow and the sustainability of the environments they grow in," explained Professor Eske Willerslev.

Reinventing agroecosystems

As a part of the initiative, a global hub of environmental genomics expertise will be established at the University of Copenhagen. Central to this hub is the data engine, a core unit dedicated to extracting and analysing ancient eDNA from sediment cores, offering a window into the Earth's agrarian history and the response of ecosystems to changes over hundreds to millions of years.

This groundbreaking work will harness the collective expertise in bioinformatics, microbial ecology, plant breeding, and environmental genomics to move scientific frontiers and develop new approaches to designing stable and resilient agroecosystems. The ultimate goal is to provide a robust knowledge base and tools for the global community to advance agriculture in the face of climatic adversity.

The Novo Nordisk Foundation anticipates that AEGIS will significantly contribute to the understanding of agroecosystem functionalities from past environmental disturbances and will demonstrate proof-of-concept in key crops such as barley, wheat, and rice.

AEGIS is committed to the principles of the Nagoya Protocol on Access and Benefit Sharing, which focusses on fair and equitable sharing of benefits arising by the utilisation of genetic resources, thereby contributing to the conservation and sustainable use of biodiversity.

About the Novo Nordisk Foundation

Established in Denmark in 1924, the Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives. The vision of the Foundation is to improve people's health and the sustainability of society and the planet. The Foundation's mission is to progress research and innovation in the prevention and treatment of cardiometabolic and infectious diseases as well as to advance knowledge and solutions to support a green transformation of society.

www.novonordiskfonden.dk/en

About Wellcome

Wellcome is a global charitable foundation, based in the UK. Wellcome supports science to solve the urgent health challenges facing everyone. We support discovery research into life, health, and wellbeing, and we're taking on three worldwide health challenges: mental health, infectious disease, and climate and health.

Cision View original content:https://www.prnewswire.co.uk/news-releases/novo-nordisk-foundation-and-the-wellcome-trust-award-a-grant-of-up-to-dkk-585-million-to-the-ancient-environmental-genomics-initiative-for-sustainability-aegis-302169719.html

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2024 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.